Showing results (151-160 of 322) with videos related to
Sort By:
Pageof 33
Blood Cancer Journal|July 11, 2026
Cancer history and second cancer risk in polycythemia vera and essential thrombocythemiaGiuseppe G Loscocco, Fnu Aperna, Moazah Iftikhar, et al.Blood Cancer Journal|October 15, 2020
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosisAlessandra Carobbio, Paola Guglielmelli, Elisa Rumi, et al.The Lancet. Oncology|December 6, 2016
Ruxolitinib for the treatment of inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): a randomised, open-label, phase 3b studyFrancesco Passamonti, Martin Griesshammer, Francesca Palandri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2012
Improving survival trends in primary myelofibrosis: an international studyFrancisco Cervantes, Brigitte Dupriez, Francesco Passamonti, et al.Blood Cancer Journal|November 24, 2018
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyureaAnnalisa Pacilli, Giada Rotunno, Carmela Mannarelli, et al.British Journal of Haematology|April 27, 2022
Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase-2 (JAK2), in patients with myelofibrosis and low pretreatment platelet countsClaire N Harrison, Nicolaas Schaap, Alessandro M Vannucchi, et al.Leukemia & Lymphoma|November 11, 2016
The potential role of hematocrit control on symptom burden among polycythemia vera patients: Insights from the CYTO-PV and MPN-SAF patient cohortsRobyn Marie Scherber, Holly Lynn Geyer, Amylou C Dueck, et al.Blood|November 8, 2008
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and TreatmentFrancisco Cervantes, Brigitte Dupriez, Arturo Pereira, et al.American Journal of Hematology|October 30, 2013
Masked polycythemia vera diagnosed according to WHO and BCSH classificationTiziano Barbui, Jürgen Thiele, Alessandra Carobbio, et al.Haematologica|September 9, 2010
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasmsPhilip A Beer, Christina A Ortmann, Frank Stegelmann, et al.Pageof 33